ZYMEWORKS INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
ZYMEWORKS INC. (ZYME) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $11.11 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- ZYMEWORKS INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $11.11M, a 92.44% increase year-over-year.
- ZYMEWORKS INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $6.88M, a 1.30% increase year-over-year.
- ZYMEWORKS INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $6.38M, a 58.32% increase year-over-year.
- ZYMEWORKS INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $5.77M, a 17.99% increase year-over-year.
- ZYMEWORKS INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $27.07M, a 61.93% increase from fiscal 2024.
- ZYMEWORKS INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $16.72M, a 103.95% increase from fiscal 2023.
- ZYMEWORKS INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $8.20M, a 13.87% decline from fiscal 2022.
- ZYMEWORKS INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $9.52M, a 75.14% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.11M 10-Q · filed 2026-08-06 | $17.99M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $6.88M 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $27.07M 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $6.38M 10-Q · filed 2025-11-06 | $12.15M derived: sum of 2 quarters · filed 2026-08-06 | $18.94M derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | $5.77M 10-Q · filed 2026-08-06 | $12.56M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $6.79M 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $16.72M 10-K · filed 2026-03-02 | |||
| 2024-09-30 | $4.03M 10-Q · filed 2025-11-06 | $8.92M derived: sum of 2 quarters · filed 2025-11-06 | $12.35M derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $4.89M 10-Q · filed 2025-11-06 | $8.33M derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $3.44M 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $8.20M 10-K · filed 2026-03-02 | |||
| 2023-09-30 | $2.69M 10-Q · filed 2024-10-31 | $3.43M derived: sum of 2 quarters · filed 2024-10-31 | $5.62M derived: sum of 3 quarters · filed 2024-10-31 | |
| 2023-06-30 | $742.00K 10-Q · filed 2024-10-31 | $2.94M derived: sum of 2 quarters · filed 2024-10-31 | ||
| 2023-03-31 | $2.20M 10-Q · filed 2024-10-31 | |||
| 2022-12-31 | $9.52M 10-K · filed 2025-03-05 | |||
| 2022-09-30 | $4.38M 10-Q · filed 2023-11-07 | $8.84M derived: sum of 2 quarters · filed 2023-11-07 | $5.90M derived: sum of 3 quarters · filed 2023-11-07 | |
| 2022-06-30 | $4.45M 10-Q · filed 2023-11-07 | $1.52M derived: sum of 2 quarters · filed 2023-11-07 | ||
| 2022-03-31 | -$2.93M 10-Q · filed 2023-11-07 | |||
| 2021-12-31 | $38.27M 10-K · filed 2024-03-06 | |||
| 2021-09-30 | $10.33M 10-Q · filed 2022-11-08 | $21.42M derived: sum of 2 quarters · filed 2022-11-08 | $29.95M derived: sum of 3 quarters · filed 2022-11-08 | |
| 2021-06-30 | $11.09M 10-Q · filed 2022-11-08 | $19.62M derived: sum of 2 quarters · filed 2022-11-08 | ||
| 2021-03-31 | $8.53M 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | $26.95M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |